Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease

Alzheimer's disease (AD) is a devastating neurodegenerative disorder that threatens to reach epidemic proportions as our population ages. Although much research has examined molecular pathways associated with AD, relatively few such studies have focused on the disease's critical early stages. In a prior microarray study we correlated gene expression in hippocampus with degree of Alzheimer's disease and found close associations between upregulation of apparent glial transcription factor/epigenetic/tumor suppressor genes and incipient AD. The results suggested a new model in which AD pathology spreads along myelinated axons (Blalock et al., 2004). However, the microarray analyses were performed on RNA extracted from frozen hand-dissected hippocampal CA1 tissue blocks containing both gray and white matter, limiting the confidence with which transcriptional changes in gray matter could be distinguished from those in white matter. Here, we used laser capture microdissection (LCM) to exclude major white matter tracts while selectively collecting CA1 hippocampal gray matter from formalin-fixed, paraffin-embedded (FFPE) hippocampal sections of the same subjects assessed in our prior study. Microarray analyses of this gray matter-enriched tissue revealed many transcriptional changes similar to those seen in our past study and in studies by others, particularly for downregulated neuron-related genes. Additionally, the present analyses identified several previously undetected pathway alterations, including downregulation of molecules that stabilize ryanodine receptor Ca2+ release and upregulation of vasculature development. Conversely, we found a striking paucity of the upregulated changes in the putative glial and growth-related genes that had been strongly overrepresented in the prior mixed-tissue study. We conclude that FFPE tissue can be a reliable resource for microarray studies of brain tissue, that upregulation of growth-related epigenetic/transcription factors during incipient AD is predominantly localized in and around white matter (supporting our prior findings and model), and that novel alterations in vascular and ryanodine receptor-related pathways in gray matter are closely associated with incipient AD.

[1]  G. Johnson,et al.  Tau, where are we now? , 2002, Journal of Alzheimer's disease : JAD.

[2]  Olivier Thibault,et al.  Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store , 2007, Aging cell.

[3]  M. Ball,et al.  Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling , 2002, Journal of neuroscience research.

[4]  D. Butterfield,et al.  Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder. , 2007 .

[5]  A. Granholm,et al.  Nerve growth factor in treatment and pathogenesis of Alzheimer's disease , 2006, Progress in Neurobiology.

[6]  Roberta Diaz Brinton,et al.  Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease. , 2008, Advanced drug delivery reviews.

[7]  G. Casadesus,et al.  A Metabolic Basis for Alzheimer Disease , 2003, Neurochemical Research.

[8]  J. Heath,et al.  Gene expression profiling of RNA extracted from FFPE tissues: NuGEN technologies' whole-transcriptome amplification system. , 2011, Methods in molecular biology.

[9]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  T B Shea,et al.  Calcium‐Activated Neutral Proteinase (Calpain) System in Aging and Alzheimer's Disease a , 1994, Annals of the New York Academy of Sciences.

[11]  Douglas Walker,et al.  Inflammation and Alzheimer's disease pathogenesis , 1996, Neurobiology of Aging.

[12]  G. Pasinetti,et al.  Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia , 2001, Journal of neuroscience research.

[13]  E. Blalock,et al.  Disrupting Function of FK506-Binding Protein 1b/12.6 Induces the Ca2+-Dysregulation Aging Phenotype in Hippocampal Neurons , 2011, The Journal of Neuroscience.

[14]  Ron Edgar,et al.  Gene Expression Omnibus ( GEO ) : Microarray data storage , submission , retrieval , and analysis , 2008 .

[15]  John Q Trojanowski,et al.  ‘Unfolding’ pathways in neurodegenerative disease , 2003, Trends in Neurosciences.

[16]  P. Bickford,et al.  Diets Enriched in Foods with High Antioxidant Activity Reverse Age-Induced Decreases in Cerebellar β-Adrenergic Function and Increases in Proinflammatory Cytokines , 2002, The Journal of Neuroscience.

[17]  T. Triche,et al.  Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays. , 2010, The Journal of molecular diagnostics : JMD.

[18]  Ilya Bezprozvanny,et al.  Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease , 2008, Trends in Neurosciences.

[19]  Meaghan Morris,et al.  The Many Faces of Tau , 2011, Neuron.

[20]  C. Dobson,et al.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution , 2003, Journal of Molecular Medicine.

[21]  S. Scheff,et al.  Alzheimer's disease-related synapse loss in the cingulate cortex. , 2001, Journal of Alzheimer's disease : JAD.

[22]  P. Coleman,et al.  Defects in expression of genes related to synaptic vesicle traffickingin frontal cortex of Alzheimer’s disease , 2003, Neurobiology of Disease.

[23]  N. Sewankambo,et al.  Comparison of methods in the recovery of nucleic acids from archival formalin-fixed paraffin-embedded autopsy tissues. , 2010, Analytical biochemistry.

[24]  G. Gibson,et al.  Calcium and the aging nervous system , 1987, Neurobiology of Aging.

[25]  F. LaFerla,et al.  Enhanced Ryanodine‐Mediated Calcium Release in Mutant PS1‐Expressing Alzheimer's Mouse Models , 2007, Annals of the New York Academy of Sciences.

[26]  E. Barrett-Connor,et al.  Diabetes, impaired fasting glucose, and development of cognitive impairment in older women , 2004, Neurology.

[27]  Z. Khachaturian The role of calcium regulation in brain aging: reexamination of a hypothesis , 1989, Aging.

[28]  A. Stromberg,et al.  Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: Statistical reliability and functional correlation , 2005, Ageing Research Reviews.

[29]  J. Trojanowski,et al.  Expression profile of transcripts in Alzheimer's disease tangle‐bearing CA1 neurons , 2000, Annals of neurology.

[30]  B. Yankner,et al.  Neural mechanisms of ageing and cognitive decline , 2010, Nature.

[31]  F. Sohrabji,et al.  Estrogen–BDNF interactions: Implications for neurodegenerative diseases , 2006, Frontiers in Neuroendocrinology.

[32]  E. Mufson,et al.  Single cell gene expression profiling in Alzheimer’s disease , 2006, NeuroRX.

[33]  R. Weindruch,et al.  Microglia and Aging in the Brain , 2002 .

[34]  C. Finch,et al.  Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? , 2001, Trends in Neurosciences.

[35]  P. Mathews,et al.  The neuronal endosomal-lysosomal system in Alzheimer's disease. , 2001, Journal of Alzheimer's disease : JAD.

[36]  P. Landfield ‘Increased calcium-current’ hypothesis of brain aging , 1987, Neurobiology of Aging.

[37]  M. Milisavljević,et al.  Microvascular anatomy of the hippocampal formation. , 1992, Surgical neurology.

[38]  T. Arendt,et al.  Activated Mitogenic Signaling Induces a Process of Dedifferentiation in Alzheimer's Disease That Eventually Results in Cell Death , 2000, Annals of the New York Academy of Sciences.

[39]  Suzanne Craft,et al.  Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. , 2007, Current Alzheimer research.

[40]  J F Disterhoft,et al.  The Calcium Rationale in Aging and Alzheimer's Disease , 1994, Annals of the New York Academy of Sciences.

[41]  Kazuyuki Takata,et al.  Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo , 2003, Neuron.

[42]  D. Gustafson Adiposity indices and dementia , 2006, The Lancet Neurology.

[43]  Aristide Merola,et al.  Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter , 2009, Journal of neuropathology and experimental neurology.

[44]  M. Michaelis,et al.  Decreased plasma membrane calcium transport activity in aging brain. , 1996, Life sciences.

[45]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[46]  E. Mufson,et al.  Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. , 2007, Current Alzheimer research.

[47]  J M Lee,et al.  A gene expression profile of Alzheimer's disease. , 2001, DNA and cell biology.

[48]  R. Boyce,et al.  Preliminary Comparison of Quantity, Quality, and Microarray Performance of RNA Extracted From Formalin-fixed, Paraffin-embedded, and Unfixed Frozen Tissue Samples , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[49]  B. Hyman,et al.  Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid β-peptide , 2001, Nature Cell Biology.

[50]  P. Bickford,et al.  Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats , 2000, Brain Research.

[51]  Vicki Olm,et al.  Statin therapy for Alzheimer’s disease , 2002, Journal of Molecular Neuroscience.

[52]  D. Morgan Learning and Memory Deficits in APP Transgenic Mouse Models of Amyloid Deposition , 2003, Neurochemical Research.

[53]  R. Bowser,et al.  Cell cycle proteins in Alzheimer's disease: plenty of wheels but no cycle. , 2002, Journal of Alzheimer's disease : JAD.

[54]  The molecular genetics of Alzheimer's disease , 1994 .

[55]  R. Neve,et al.  Microarray Analysis of Hippocampal CA1 Neurons Implicates Early Endosomal Dysfunction During Alzheimer's Disease Progression , 2010, Biological Psychiatry.

[56]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[57]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[58]  T. Foster,et al.  Reversal of Age-Related Alterations in Synaptic Plasticity by Blockade of L-Type Ca2+ Channels , 1998, The Journal of Neuroscience.

[59]  R. Mrak,et al.  Interleukin-1, neuroinflammation, and Alzheimer’s disease , 2001, Neurobiology of Aging.

[60]  E. Lein,et al.  Transcriptional profiling reveals strict boundaries between hippocampal subregions , 2001, The Journal of comparative neurology.

[61]  R. Stoyanova,et al.  Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue. , 2007, The Journal of molecular diagnostics : JMD.

[62]  K. Yaffe,et al.  Body mass index in midlife and risk of Alzheimer disease and vascular dementia. , 2007, Current Alzheimer research.

[63]  Grace E. Stutzmann Calcium Dysregulation, IP3 Signaling, and Alzheimer’s Disease , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[64]  F. Gage,et al.  Potential use of neurotrophic agents in the treatment of neurodegenerative disorders. , 1990, Acta neurobiologiae experimentalis.

[65]  Lars Bertram,et al.  New Frontiers in Alzheimer's Disease Genetics , 2001, Neuron.

[66]  Xinkun Wang,et al.  Functional Genomics of Brain Aging and Alzheimer’s Disease: Focus on Selective Neuronal Vulnerability , 2010, Current genomics.

[67]  Corinna Burger,et al.  Region-Specific Genetic Alterations in the Aging Hippocampus: Implications For Cognitive Aging , 2010, Front. Ag. Neurosci..

[68]  D. Price,et al.  Loss of the Presynaptic Vesicle Protein Synaptophysin in Hippocampus Correlates with Cognitive Decline in Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[69]  A. Owen,et al.  AGEMAP: A Gene Expression Database for Aging in Mice , 2007, PLoS genetics.

[70]  E. Blalock,et al.  Aging-Related Gene Expression in Hippocampus Proper Compared with Dentate Gyrus Is Selectively Associated with Metabolic Syndrome Variables in Rhesus Monkeys , 2010, The Journal of Neuroscience.

[71]  P. Davies,et al.  Mechanism-based treatments for Alzheimer's disease , 2009, Dialogues in clinical neuroscience.

[72]  C. Norris,et al.  Age‐associated changes in Ca2+‐dependent processes: Relation to hippocampal synaptic plasticity , 1997 .

[73]  E. Blalock,et al.  A new glucocorticoid hypothesis of brain aging: implications for Alzheimer's disease. , 2007, Current Alzheimer research.

[74]  Y. Benjamini,et al.  More powerful procedures for multiple significance testing. , 1990, Statistics in medicine.

[75]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[76]  D. Price,et al.  Mutant genes in familial Alzheimer's disease and transgenic models. , 1998, Annual review of neuroscience.

[77]  E. Masliah,et al.  Synaptic and neuritic alterations during the progression of Alzheimer's disease , 1994, Neuroscience Letters.

[78]  Richard D. Kennedy,et al.  RNA expression analysis from formalin fixed paraffin embedded tissues , 2008, Histochemistry and Cell Biology.

[79]  J. Simpkins,et al.  Role of Nonfeminizing Estrogens in Brain Protection from Cerebral Ischemia: An Animal Model of Alzheimer's Disease Neuropathology , 2005, Annals of the New York Academy of Sciences.

[80]  J. Ambati Age-related macular degeneration and the other double helix. The Cogan Lecture. , 2011, Investigative ophthalmology & visual science.

[81]  Eric M Reiman,et al.  Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. , 2008, Physiological genomics.